Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider

Link to claim CME credit: https://bit.ly/4uRr3ir

In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, including:

• First-line treatment options available for EGFR-mutated NSCLC and the clinical trials that resulted in their approval
• Adverse event identification and management
• Generalized strategies to support patient adherence to TKIs

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Podcast on Apple Podcasts, YouTube Music, or Spotify

Presenters:

Elizabeth Krueger, NP Center for Thoracic Cancers Mass General Brigham Cancer Institute Boston, Massachusetts

Sam Vafadar, DHSc, PA-C Physician Associate Department of Thoracic Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.